
The Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC) has recommended that COVID-19 vaccination should no longer be a universal requirement for everyone over the age of six months, but rather an individualized decision. According to the
Read more: “CDC shifts vaccination strategy, leaving COVID-19 shots to patients”

The U.S. Food and Drug Administration (FDA) has approved a new subcutaneous formulation of Keytruda, Merck’s flagship immunotherapy for cancer. This version, called Keytruda Qlex, represents a significant advancement in how the treatment is administered, as it allows patients to receive their dose
Read more: "FDA Approves Subcutaneous Version of Keytruda for Cancer Patients"





